This WIREs title offers downloadable PowerPoint presentations of figures for non-profit,
educational use, provided the content is not modified and full credit is given to the author
and publication.
References 1 Semenza, GL, Wang, GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992; 12: 5447–5454. 2 Wang, GL, Jiang, B‐H, Rue, EA, Semenza, GL. Hypoxia‐inducible factor 1 is a basic‐helix‐loop‐helix‐PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 1995; 92: 5510–5514. 3 Wang, GL, Semenza, GL. Purification and characterization of hypoxia‐inducible factor 1. J Biol Chem 1995; 270: 1230–1237. 4 Ema, M, Taya, S, Yokotani, N, Sogawa, K, Matsuda, Y, et al. A novel bHLH‐PAS factor with close sequence similarity to hypoxia‐inducible factor 1α regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 1997; 94: 4273–4278. 5 Flamme, I, Fröhlich, T, von Reutern, M, Kappel, A, Damert, A, et al. HRF, a putative basic helix‐loop‐helix‐PAS‐domain transcription factor is closely related to hypoxia‐inducible factor‐1α and developmentally expressed in blood vessels. Mech Dev 1997; 63: 51–60. 6 Hogenesch, JB, Chan, WK, Jackiw, VH, Brown, RC, Gu, YZ, et al. Characterization of a subset of the basic‐helix‐loop‐helix‐PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem 1997; 272: 8581–8593. 7 Tian, H, McKnight, SL, Russell, DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 1997; 11: 72–82. 8 Wiesener, MS, Turley, H, Allen, WE, Willam, C, Eckardt, KU, et al. Induction of endothelial PAS domain protein‐1 by hypoxia: characterization and comparison with hypoxia‐inducible factor‐1α. Blood 1998; 92: 2260–2268. 9 Patel, SA, Simon, MC. Biology of hypoxia‐inducible factor‐2α in development and disease. Cell Death Differ 2008; 15: 628–634. 10 Jiang, BH, Rue, E, Wang, GL, Roe, R, Semenza, GL. Dimerization, DNA binding, and transactivation properties of hypoxia‐inducible factor 1. J Biol Chem 1996; 271: 17771–17778. 11 Reyes, H, Reisz‐Porszasz, S, Hankinson, O. Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992; 256: 1193–1195. 12 Gu, YZ, Hogenesch, JB, Bradfield, CA. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000; 40: 519–561. 13 Yu, AY, Frid, MG, Shimoda, LA, Wiener, CM, Stenmark, K, et al. Temporal, spatial, and oxygen‐regulated expression of hypoxia‐inducible factor‐1 in the lung. Am J Physiol 1998; 275: L818–L826. 14 Bergeron, M, Yu, AY, Solway, KE, Semenza, GL, Sharp, FR. Induction of hypoxia‐inducible factor‐1 (HIF‐1) and its target genes following focal ischaemia in rat brain. Eur J Neurosci 1999; 11: 4159–4170. 15 Rius, J, Guma, M, Schachtrup, C, Akassoglou, K, Zinkernagel, AS, et al. NF‐κB links innate immunity to the hypoxic response through transcriptional regulation of HIF‐1α. Nature 2008; 453: 807–811. 16 van Uden, P, Kenneth, NS, Rocha, S. Regulation of hypoxia‐inducible factor‐1α by NF‐κB. Biochem J 2008; 412: 477–484. 17 Thomas, JD, Johannes, GJ. Identification of mRNAs that continue to associate with polysomes during hypoxia. RNA 2007; 13: 1116–1131. 18 van den Beucken, T, Koritzinsky, M, Wouters, BG. Translational control of gene expression during hypoxia. Cancer Biol Ther 2006; 5: 749–755. 19 Lang, KJ, Kappel, A, Goodall, GJ. Hypoxia‐inducible factor‐1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol Biol Cell 2002; 13: 1792–1801. 20 Schepens, B, Tinton, SA, Bruynooghe, Y, Beyaert, R, Cornelis, S. The polypyrimidine tract‐binding protein stimulates HIF‐1α IRES‐mediated translation during hypoxia. Nucleic Acids Res 2005; 33: 6884–6894. 21 Galbán, S, Kuwano, Y, Pullmann, R Jr , Martindale, JL, Kim, HH, Lal, A, et al. RNA‐binding proteins HuR and PTB promote the translation of hypoxia‐inducible factor 1α. Mol Cell Biol 2008; 28: 93–107. 22 Young, RM, Wang, SJ, Gordan, JD, Ji, X, Liebhaber, SA, Simon, MC. Hypoxia‐mediated selective mRNA translation by an internal ribosome entry site‐independent mechanism. J Biol Chem 2008; 283: 16309–16319. 23 Laughner, E, Taghavi, P, Chiles, K, Mahon, PC, Semenza, GL. HER2 (neu) signaling increases the rate of hypoxia‐inducible factor 1α (HIF‐1α) synthesis: novel mechanism for HIF‐1‐mediated vascular endothelial growth factor expression. Mol Cell Biol 2001; 21: 3995–4004. 24 Zhong, H, Chiles, K, Feldser, D, Laughner, E, Hanrahan, C, et al. Modulation of hypoxia‐inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3‐kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 2000; 60: 1541–1545. 25 Arsham, AM, Howell, JJ, Simon, MC. A novel hypoxia‐inducible factor‐independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 2003; 278: 29655–29660. 26 Brugarolas, J, Lei, K, Hurley, RL, Manning, BD, Reiling, JH, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev 2004; 18: 2893–2904. 27 Taguchi, A, Yanagisawa, K, Tanaka, M, Cao, K, Matsuyama, Y, et al. Identification of hypoxia‐inducible factor 1α as a novel target for miR‐17‐92 microRNA cluster. Cancer Res 2008; 68: 5540–5545. 28 Mastrogiannaki, M, Matak, P, Keith, B, Simon, MC, Vaulont, S, et al. HIF‐2α, but not HIF‐1α, promotes iron absorption in mice. J Clin Invest 2009; 119: 1159–1166. 29 Sanchez, M, Galy, B, Muckenthaler, MU, Hentze, MW. Iron‐regulatory proteins limit hypoxia‐inducible factor‐2α expression in iron deficiency. Nat Struct Mol Biol 2007; 14: 420–426. 30 Jewell, UR, Kvietikova, I, Scheid, A, Bauer, C, Wenger, RH, et al. Induction of HIF‐1α in response to hypoxia is instantaneous. FASEB J 2001; 15: 1312–1314. 31 Jiang, B‐H, Semenza, GL, Bauer, C, Marti, HH. Hypoxia‐inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am J Physiol 1996; 271: C1172–C1180. 32 Kaelin, WG Jr, Ratcliffe, PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 2008; 30: 393–402. 33 Chowdhury, R, Hardy, A, Schofield, CJ. The human oxygen sensing machinery and its manipulation. Chem Soc Rev 2008; 37: 1308–1319. 34 Berra, E, Benizri, E, Ginouvès, A, Volmat, V, Roux, D, et al. HIF prolyl‐hydroxylase 2 is the key oxygen sensor setting low steady‐state levels of HIF‐1α in normoxia. EMBO J 2003; 22: 4082–4090. 35 Baek, JH, Mahon, PC, Oh, J, Kelly, B, Krishnamachary, B, et al. OS‐9 interacts with hypoxia‐inducible factor 1α and prolyl hydroxylases to promote oxygen‐dependent degradation of HIF‐1α. Mol Cell 2005; 17: 503–512. 36 Elvidge, GP, Glenny, L, Appelhoff, RJ, Ratcliffe, PJ, Ragoussis, J, et al. Concordant regulation of gene expression by hypoxia and 2‐oxoglutarate‐dependent dioxygenase inhibition: the role of HIF‐1α, HIF‐2α, and other pathways. J Biol Chem 2006; 281: 15215–15226. 37 Kaelin, WG. Von Hippel‐Lindau disease. Annu Rev Pathol 2007; 2: 145–173. 38 Baek, JH, Liu, YV, McDonald, KR, Wesley, JB, Hubbi, ME, et al. Spermidine/spermine‐N1‐acetyl‐ transferase 2 is an essential component of the ubiquitin ligase complex that regulates hypoxia‐inducible factor 1α. J Biol Chem 2007; 282: 23572–23580. 39 Maxwell, PH, Wiesener, MS, Chang, GW, Clifford, SC, et al. The tumor suppressor protein VHL targets hypoxia‐inducible factors for oxygen‐dependent proteolysis. Nature 1999; 399: 271–275. 40 Li, Z, Wang, D, Messing, EM, Wu, G. VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α. EMBO Rep 2005; 6: 373–378. 41 Li, Z, Wang, D, Messing, EM, Wu, G. Identification of a deubiquitinating enzyme subfamily as substrates of the von Hippel‐Lindau tumor suppressor. Biochem Biophys Res Commun 2002; 294: 700–709. 42 Rane, S, He, M, Sayed, D, Vashistha, H, Malhotra, A, et al. Downregulation of miR‐199a derepresses hypoxia‐inducible factor‐1α and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res 2009; 104: 879–886. 43 Gradin, K, McGuire, J, Wenger, RH, Kvietikova, I, Whitelaw, ML, et al. Functional interference between hypoxia and dioxin signal transduction pathways: competition for recruitment of the Arnt transcription factor. Mol Cell Biol 1996; 16: 5221–5231. 44 Minet, E, Mottet, D, Michel, G, Roland, I, Raes, M, et al. Hypoxia‐induced activation of HIF‐1: role of HIF‐1α‐Hsp90 interaction. FEBS Lett 1999; 460: 251–256. 45 Isaacs, JS, Jung, YJ, Mimnaugh, EG, Martinez, A, Cuttitta, F, et al. Hsp90 regulates a von Hippel Lindau‐independent hypoxia‐inducible factor‐1α‐degradative pathway. J Biol Chem 2002; 277: 29936–29944. 46 Liu, YV, Baek, JH, Zhang, H, Diez, R, Cole, RN, et al. RACK1 competes with HSP90 for binding to HIF‐1α and is required for O2 ‐independent and HSP90 inhibitor‐induced degradation of HIF‐1α. Mol Cell 2007; 25: 207–217. 47 Baek, JH, Liu, YV, McDonald, KR, Wesley, JB, Zhang, H, et al. Spermidine/spermine N1 ‐acetyl‐ transferase‐1 binds to hypoxia‐inducible factor‐1α (HIF‐1α) and RACK1 and promotes ubiquitination and degradation of HIF‐1α. J Biol Chem 2007; 282: 33358–33366. 48 Liu, YV, Hubbi, ME, Pan, F, McDonald, KR, Mansharamani, M, et al. Calcineurin promotes hypoxia‐inducible factor 1α expression by dephosphorylating RACK1 and blocking RACK1 dimerization. J Biol Chem 2007; 282: 37064–37073. 49 Cheng, J, Kang, X, Zhang, S, Yeh, ET. SUMO‐specific protease 1 is essential for stabilization of HIF‐1α during hypoxia. Cell 2007; 131: 584–595. 50 Carbia‐Nagashima, A, Gerez, J, Perez‐Castro, C, Paez‐Pereda, M, Silberstein, S, et al. RSUME, a small RWD‐containing protein, enhances SUMO conjugation and stabilizes HIF‐1α during hypoxia. Cell 2007; 131: 309–323. 51 Jiang, BH, Zheng, JZ, Leung, SW, Roe, R, Semenza, GL. Transactivation and inhibitory domains of hypoxia‐inducible factor 1α. Modulation of transcriptional activity by oxygen tension. J Biol Chem 1997; 272: 19253–19260. 52 Pugh, CW, O`Rourke, JF, Nagao, M, Gleadle, JM, Ratcliffe, PJ. Activation of hypoxia‐inducible factor‐1; definition of regulatory domains within the α subunit. J Biol Chem 1997; 272: 11205–11214. 53 Mahon, PC, Hirota, K, Semenza, GL. FIH‐1: a novel protein that interacts with HIF‐1α and VHL to mediate repression of HIF‐1 transcriptional activity. Genes Dev 2001; 15: 2675–2686. 54 Lando, D, Peet, DJ, Gorman, JJ, Whelan, DA, Whitelaw, ML, et al. FIH‐1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia‐inducible factor. Genes Dev 2002; 16: 1466–1471. 55 Peng, ZG, Zhou, MY, Huang, Y, Qiu, JH, Wang, LS, et al. Physical and functional interaction of Runt‐related protein 1 with hypoxia‐inducible factor‐1α. Oncogene 2008; 27: 839–847. 56 Jeong, JW, Bae, MK, Ahn, MY, Kim, SH, Sohn, TK, et al. Regulation and destabilization of HIF‐1α by ARD1‐mediated acetylation. Cell 2002; 111: 709–720. 57 Hogenesch, JB, Gu, YZ, Jain, S, Bradfield, CA. The basic‐helix‐loop‐helix‐PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc Natl Acad Sci U S A 1998; 95: 5474–5479. 58 Takahata, S, Sogawa, K, Kobayashi, A, Ema, M, Mimura, J, et al. Transcriptionally active heterodimer formation of an Arnt‐like PAS protein, Arnt3, with HIF‐1α, HLF, and clock. Biochem Biophys Res Commun 1998; 248: 789–794. 59 LaRusch, GA, Jackson, MW, Dunbar, JD, Warren, RS, Donner, DB, et al. Nutlin3 blocks vascular endothelial growth factor induction by preventing the interaction between hypoxia inducible factor 1α and Hdm2. J Biol Chem 2006; 281: 16814–16820. 60 Kaidi, A, Williams, AC, Paraskeva, C. Interaction between β‐catenin and HIF‐1 promotes cellular adaptation to hypoxia. Nat Cell Biol 2007; 9: 210–217. 61 Ema, M, Hirota, K, Mimura, J, Abe, H, Yodoi, J, et al. Molecular mechanisms of transcription activation by HLF and HIF‐1α in response to hypoxia: their stabilization and redox signal‐induced interaction with CBP/p300. EMBO J 1999; 18: 1905–1914. 62 Carrero, P, Okamoto, K, Coumailleau, P, O`Brien, S, Tanaka, H, et al. Redox‐regulated recruitment of the transcriptional coactivators CREB‐binding protein and SRC‐1 to hypoxia‐inducible factor 1α. Mol Cell Biol 2000; 20: 402–415. 63 Jiang, Y, Xue, ZH, Shen, WZ, Du, KM, Yan, H, et al. Desferrioxamine induces leukemic cell differentiation potentially by hypoxia‐inducible factor‐1α that augments transcriptional activity of CCAAT/enhancer‐binding protein‐α. Leukemia 2005; 19: 1239–1247. 64 van de Sluis, B, Muller, P, Duran, K, Chen, A, Groot, AJ, et al. Increased activity of hypoxia‐inducible factor 1 is associated with early embryonic lethality in Commd1 mice. Mol Cell Biol 2007; 27: 4142–4156. 65 Ao, A, Wang, H, Kamarajugadda, S, Lu, J. Involvement of estrogen‐related receptors in transcriptional response to hypoxia and growth of solid tumors. Proc Natl Acad Sci U S A 2008; 105: 7821–7826. 66 Koh, MY, Darnay, BG, Powis, G. Hypoxia‐associated factor, a novel E3‐ubiquitin ligase, binds and ubiquitinates hypoxia‐inducible factor 1α, leading to its oxygen‐independent degradation. Mol Cell Biol 2008; 28: 7081–7095. 67 Kato, H, Tamamizu‐Kato, S, Shibasaki, F. Histone deacetylase 7 associates with hypoxia‐inducible factor 1α and increases transcriptional activity. J Biol Chem 2004; 279: 41966–41974. 68 Moon, EJ, Jeong, CH, Jeong, JW, Kim, KR, Yu, DY, et al. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia‐inducible factor‐1α. FASEB J 2004; 18: 382–384. 69 Zhang, W, Tsuchiya, T, Yasukochi, Y. Transitional change in interaction between HIF‐1 and HNF‐4 in response to hypoxia. J Hum Genet 1999; 44: 293–299. 70 Tendler, DS, Bao, C, Wang, T, Huang, EL, Ratovitski, EA, et al. Intersection of interferon and hypoxia signal transduction pathways in nitric oxide‐induced tumor apoptosis. Cancer Res 2001; 61: 3682–3688. 71 Bae, MK, Ahn, MY, Jeong, JW, Bae, MH, Lee, YM, et al. Jab1 interacts directly with HIF‐1α and regulates its stability. J Biol Chem 2002; 277: 9–12. 72 Cai, Q, Murakami, M, Si, H, Robertson, ES. A potential α‐helix motif in the amino terminus of LANA encoded by Kaposi`s sarcoma‐associated herpesvirus is critical for nuclear accumulation of HIF‐1α in normoxia. J Virol 2007; 81: 10413–10423. 73 Hogenesch, JB, Gu, YZ, Moran, SM, Shimomura, K, Radcliffe, LA, et al. The basic helix‐loop‐helix‐PAS protein MOP9 is a brain‐specific heterodimeric partner of circadian and hypoxia factors. J Neurosci 2000; 20: RC83. 74 Amir, S, Wang, R, Matzkin, H, Simons, JW, Mabjeesh, NJ. MSF‐A interacts with hypoxia‐inducible factor‐1α and augments hypoxia‐inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. Cancer Res 2006; 66: 856–866. 75 Yoo, YG, Kong, G, Lee, MO. Metastasis‐associated protein 1 enhances stability of hypoxia‐inducible factor‐1α protein by recruiting histone deacetylase 1. EMBO J 2006; 25: 1231–1241. 76 Koshiji, M, Kageyama, Y, Pete, EA, Horikawa, I, Barrett, JC, et al. HIF‐1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004; 23: 1949–1956. 77 Moon, HE, Ahn, MY, Park, JA, Min, KJ, Kwon, YW, et al. Negative regulation of hypoxia inducible factor‐1 alpha by necdin. FEBS Lett 2005; 579: 3797–3801. 78 Gustafsson, MV, Zheng, X, Pereira, T, Gradin, K, Jin, S, et al. Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 2005; 9: 617–628. 79 Fatyol, K, Szalay, AA. The p14ARF tumor suppressor protein facilitates nucleolar sequestration of hypoxia‐inducible factor‐1α (HIF‐1α) and inhibits HIF‐1‐mediated transcription. J Biol Chem 2001; 276: 28421–28429. 80 An, WG, Kanekal, M, Simon, MC, Maltepe, E, Blagosklonny, MV, et al. Stabilization of wild‐type p53 by hypoxia‐inducible factor 1α. Nature 1998; 392: 405–408. 81 Ravi, R, Mookerjee, B, Bhujwalla, ZM, Sutter, CH, Artemov, D, et al. Regulation of tumor angiogenesis by p53‐induced degradation of hypoxia‐inducible factor 1α. Genes Dev 2000; 14: 34–44. 82 Arany, Z, Huang, LE, Eckner, R, Bhattacharya, S, Jiang, C, et al. An essential role for p300/CBP in the cellular response to hypoxia. Proc Natl Acad Sci U S A 1996; 93: 12969–12973. 83 Chilov, D, Hofer, T, Bauer, C, Wenger, RH, Gassmann, M. Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain. FASEB J 2001; 15: 2613–2622. 84 Koyanagi, S, Kuramoto, Y, Nakagawa, H, Aramaki, H, Ohdo, S, et al. A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 2003; 63: 7277–7283. 85 Cho, S, Choi, YJ, Kim, JM, Jeong, ST, Kim, JH, et al. Binding and regulation of HIF‐1α by a subunit of the proteasome complex, PSMA7. FEBS Lett 2001; 498: 62–66. 86 Land, SC, Tee, AR. Hypoxia‐inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif. J Biol Chem 2007; 282: 20534–20543. 87 Budde, A, Schneiderhan‐Marra, N, Petersen, G, Brüne, B. Retinoblastoma susceptibility gene product pRB activates hypoxia‐inducible factor‐1 (HIF‐1). Oncogene 2005; 24: 1802–1808. 88 Amir, S, Wang, R, Simons, JW, Mabjeesh, NJ. SEPT9_v1 up‐regulates hypoxia‐inducible factor 1 by preventing its RACK1‐mediated degradation. J Biol Chem 2009; 284: 11142–11151. 89 Sánchez‐Elsner, T, Botella, LM, Velasco, B, Corbí, A, Attisano, L, et al. Synergistic cooperation between hypoxia and transforming growth factor‐β pathways on human vascular endothelial growth factor gene expression. J Biol Chem 2001; 276: 38527–38535. 90 Koshiji, M, To, KK, Hammer, S, Kumamoto, K, Harris, AL, et al. HIF‐1α induces genetic instability by transcriptionally downregulating MutSα expression. Mol Cell 2005; 17: 793–803. 91 Hägele, S, Behnam, B, Borter, E, Wolfe, J, Paasch, U, et al. TSGA10 prevents nuclear localization of the hypoxia‐inducible factor (HIF)‐1α. FEBS Lett 2006; 580: 3731–3738. 92 Manalo, DJ, Rowan, A, Lavoie, T, Natarajan, L, Kelly, BD, et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF‐1. Blood 2005; 105: 659–669. 93 Semenza, GL, Jiang, BH, Leung, SW, Passantino, R, Concordet, JP, et al. Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia‐inducible factor 1. J Biol Chem 1996; 271: 32529–32537. 94 Krishnamurthy, P, Ross, DD, Nakanishi, T, Bailey‐Dell, K, Zhou, S, et al. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 2004; 279: 24218–24225. 95 Eckhart, AD, Yang, N, Xin, X, Faber, JE. Characterization of the α1 B ‐adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci U S A 1997; 94: 9487–9492. 96 Cormier‐Regard, S, Nguyen, SV, Claycomb, WC. Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J Biol Chem 1998; 273: 17787–17792. 97 Iyer, NV, Kotch, LE, Agani, F, Leung, SW, Laughner, E, et al. Cellular and developmental control of O2 homeostasis by hypoxia‐inducible factor 1α. Genes Dev 1998; 12: 149–162. 98 Ryan, HE, Lo, J, Johnson, RS. HIF‐1α is required for solid tumor formation and embryonic vascularization. EMBO J 1998; 17: 3005–3015. 99 Eyries, M, Siegfried, G, Ciumas, M, Montagne, K, Agrapart, M, et al. Hypoxia‐induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ Res 2008; 103: 432–440. 100 Chun, YS, Hyun, JY, Kwak, YG, Kim, IS, Kim, CH, et al. Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia‐inducible factor‐1. Biochem J 2003; 370: 149–157. 101 Weidemann, A, Klanke, B, Wagner, M, Volk, T, Willam, C, et al. Hypoxia, via stabilization of the hypoxia‐inducible factor HIF‐1α is a direct and sufficient stimulus for brain‐type natriuretic peptide induction. Biochem J 2008; 409: 233–242. 102 Wykoff, CC, Pugh, CW, Maxwell, PH, Harris, AL, Ratcliffe, PJ. Identification of novel hypoxia dependent and independent target genes of the von Hippel‐Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene 2000; 19: 6297–6305. 103 Kokkonen, N, Ulibarri, IF, Kauppila, A, Luosujärvi, H, Rivinoja, A, et al. Hypoxia upregulates carcinoembryonic antigen expression in cancer cells. Int J Cancer 2007; 121: 2443–2450. 104 Kong, T, Eltzschig, HK, Karhausen, J, Colgan, SP, Shelley, CS. Leukocyte adhesion during hypoxia is mediated by HIF‐1‐dependent induction of β2 integrin gene expression. Proc Natl Acad Sci U S A 2004; 101: 10440–10445. 105 Mukhopadhyay, CK, Mazumder, B, Fox, PL. Role of hypoxia‐inducible factor‐1 in transcriptional activation of ceruloplasmin by iron deficiency. J Biol Chem 2000; 275: 21048–21054. 106 Pennacchietti, S, Michieli, P, Galluzzo, M, Mazzone, M, Giordano, S, et al. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 2003; 3: 347–361. 107 Higgins, DF, Biju, MP, Akai, Y, Wutz, A, Johnson, RS, et al. Hypoxic induction of Ctgf is directly mediated by HIF‐1. Am J Physiol 2004; 287: F1223–F1232. 108 Kaidi, A, Qualtrough, D, Williams, AC, Paraskeva, C. Direct transcriptional up‐regulation of cyclooxygenase‐2 by hypoxia‐inducible factor (HIF)‐1 promotes colorectal tumor cell survival and enhances HIF‐1 transcriptional activity during hypoxia. Cancer Res 2006; 66: 6683–6691. 109 Fradette, C, du Souich, P. Hypoxia‐inducible factor‐1 and activator protein‐1 modulate the upregulation of CYP3A6 induced by hypoxia. Br J Pharmacol 2003; 140: 1146–1154. 110 Fukuda, R, Zhang, H, Kim, JW, Shimoda, L, Dang, CV, et al. HIF‐1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 2007; 129: 111–122. 111 Maxwell, PJ, Gallagher, R, Seaton, A, Wilson, C, Scullin, P, et al. HIF‐1 and NF‐κB‐mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells. Oncogene 2007; 26: 7333–7345. 112 Staller, P, Sulitkova, J, Lisztwan, J, Moch, H, Oakeley, EJ, et al. Chemokine receptor CXCR4 downregulated by von Hippel‐Lindau tumor suppressor pVHL. Nature 2003; 425: 307–311. 113 Schioppa, T, Uranchimeg, B, Saccani, A, Biswas, SK, Doni, A, et al. Regulation of the chemokine receptor CXCR4 by hypoxia. J Exp Med 2003; 198: 1391–1402. 114 Miyazaki, K, Kawamoto, T, Tanimoto, K, Nishiyama, M, Honda, H, et al. Identification of functional hypoxia response elements in the promoter region of the DEC1 and DEC2 genes. J Biol Chem 2002; 277: 47014–47021. 115 Simonides, WS, Mulcahey, MA, Redout, EM, Muller, A, Zuidwijk, MJ, et al. Hypoxia‐inducible factor induces local thyroid hormone inactivation during hypoxic‐ischemic disease in rats. J Clin Invest 2008; 118: 975–983. 116 Synnestvedt, K, Furuta, GT, Comerford, KM, Louis, N, Karhausen, J, et al. Ecto‐5′‐nucleotidase (CD73) regulation by hypoxia‐inducible factor‐1 mediates permeability changes in intestinal epithelia. J Clin Invest 2002; 110: 993–1002. 117 LeCouter, J, Kowalski, J, Foster, J, Hass, P, Zhang, Z, et al. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001; 412: 877–884. 118 Sánchez‐Elsner, T, Botella, LM, Velasco, B, Langa, C, Bernabéu, C. Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor‐β pathways. J Biol Chem 2002; 277: 43799–43808. 119 Coulet, F, Nadaud, S, Agrapart, M, Soubrier, F. Identification of hypoxia‐response element in the human endothelial nitric‐oxide synthase gene promoter. J Biol Chem 2003; 278: 46230–46240. 120 Hu, J, Discher, DJ, Bishopric, NH, Webster, KA. Hypoxia regulates expression of the endothelin‐1 gene through a proximal hypoxia‐inducible factor‐1 binding site on the antisense strand. Biochem Biophys Res Commun 1998; 245: 894–899. 121 Oikawa, M, Abe, M, Kurosawa, H, Hida, W, Shirato, K, et al. Hypoxia induces transcription factor ETS‐1 via the activity of hypoxia‐inducible factor‐1. Biochem Biophys Res Commun 2001; 289: 39–43. 122 Oktay, Y, Dioum, E, Matsuzaki, S, Ding, K, Yan, LJ, et al. Hypoxia‐inducible factor 2α regulates expression of the mitochondrial aconitase chaperone protein frataxin. J Biol Chem 2007; 282: 11750–11756. 123 Wood, SM, Wiesener, MS, Yeates, KM, Okada, N, Pugh, CW, et al. Selection and analysis of a mutant cell line defective in the hypoxia‐inducible factor‐1 α‐subunit (HIF‐1α). Characterization of HIF‐1α‐dependent and independent hypoxia‐inducible gene expression. J Biol Chem 1998; 273: 8360–8368. 124 Graven, KK, Yu, Q, Pan, D, Roncarati, JS, Farber, HW. Identification of an oxygen responsive enhancer element in the glyceraldehyde‐3‐phosphate dehydrogenase gene. Biochim Biophys Acta 1999; 1447: 208–218. 125 Lu, S, Gu, X, Hoestje, S, Epner, DE. Identification of an additional hypoxia responsive element in the glyceraldehyde‐3‐phosphate dehydrogenase gene promoter. Biochim Biophys Acta 2002; 1574: 152–156. 126 Paris, S, Denis, H, Delaive, E, Dieu, M, Dumont, V, et al. Up‐regulation of 94‐kDa glucose‐regulated protein by hypoxia‐inducible factor‐1 in human endothelial cells in response to hypoxia. FEBS Lett 2005; 579: 105–114. 127 Lee, PJ, Jiang, BH, Chin, BY, Iyer, NV, Alam, J, et al. Hypoxia‐inducible factor‐1 mediates transcriptional activation of the heme oxygenase‐1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375–5381. 128 Pescador, N, Cuevas, Y, Naranjo, S, Alcaide, M, Villar, D, et al. Identification of a functional hypoxia‐responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem J 2005; 390: 189–197. 129 Metzen, E, Stiehl, DP, Doege, K, Marxsen, JH, Hellwig‐Bürgel, T, et al. Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln‐1) gene: identification of a functional hypoxia‐responsive element. Biochem J 2005; 387: 711–717. 130 Lee, MJ, Kim, JY, Suk, K, Park, JH. Identification of the hypoxia‐inducible factor 1α‐responsive HGTD‐P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol 2004; 24: 3918–3927. 131 Löfstedt, T, Jögi, A, Sigvardsson, M, Gradin, K, Poellinger, L, et al. Induction of ID2 expression by hypoxia‐inducible factor‐1: a role in dedifferentiation of hypoxic neuroblastoma cells. J Biol Chem 2004; 279: 39223–39231. 132 Furuta, GT, Turner, JR, Taylor, CT, Hershberg, RM, Comerford, K, et al. Hypoxia‐inducible factor 1‐dependent induction of intestinal trefoil factor protects barrier function during hypoxia. J Exp Med 2001; 193: 1027–1034. 133 Lee, SY, Madan, A, Furuta, GT, Colgan, SP, Sibley, E. Lactase gene transcription is activated in response to hypoxia in intestinal epithelial cells. Mol Genet Metab 2002; 75: 65–69. 134 Fitsialos, G, Bourget, I, Augier, S, Ginouvès, A, Rezzonico, R, et al. HIF1 transcription factor regulates laminin‐332 expression and keratinocyte migration. J Cell Sci 2008; 121: 2992–3001. 135 Grosfeld, A, Andre, J, Hauguel‐De Mouzon, S, Berra, E, Pouyssegur, J, et al. Hypoxia‐inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002; 277: 42953–42957. 136 Erler, JT, Bennewith, KL, Nicolau, M, Dornhöfer, N, Kong, C, et al. Lysyl oxidase is essential for hypoxia‐induced metastasis. Nature 2006; 440: 1222–1226. 137 Mojsilovic‐Petrovic, J, Callaghan, D, Cui, H, Dean, C, Stanimirovic, DB, et al. Hypoxia‐inducible factor‐1 (HIF‐1) is involved in the regulation of hypoxia‐stimulated expression of monocyte chemoattractant protein‐1 (MCP‐1/CCL2) and MCP‐5 (Ccl12) in astrocytes. J Neuroinflammation 2007; 4: 12. 138 Petrella, BL, Lohi, J, Brinckerhoff, CE. Identification of membrane type‐1 matrix metalloproteinase as a target of hypoxia‐inducible factor‐2α in von Hippel‐Lindau renal cell carcinoma. Oncogene 2005; 24: 1043–1052. 139 Reynolds, PR, Mucenski, ML, Le Cras, TD, Nichols, WC, Whitsett, JA. Midkine is regulated by hypoxia and causes pulmonary vascular remodeling. J Biol Chem 2004; 279: 37124–37132. 140 Ullah, MS, Davies, AJ, Halestrap, AP. The plasma membrane lactate transporter MCT4, but not MCT1, is up‐regulated by hypoxia through a HIF‐1α‐dependent mechanism. J Biol Chem 2006; 281: 9030–9037. 141 Young, HW, Williams, OW, Chandra, D, Bellinghausen, LK, Pérez, G, et al. Central role of Muc5ac expression in mucous metaplasia and its regulation by conserved 5′ elements. Am J Respir Cell Mol Biol 2007; 37: 273–290. 142 Comerford, KM, Wallace, TJ, Karhausen, J, Louis, NA, Montalto, MC, et al. Hypoxia‐inducible factor‐1‐dependent regulation of the multidrug resistance (MDR1) gene. Cancer Res 2002; 62: 3387–3394. 143 Corn, PG, Ricci, MS, Scata, KA, Arsham, AM, Simon, MC, et al. Mxi1 is induced by hypoxia in a HIF‐1‐dependent manner and protects cells from c‐Myc‐induced apoptosis. Cancer Biol Ther 2005; 4: 1285–1294. 144 Zhang, H, Gao, P, Fukuda, R, Kumar, G, Krishnamachary, B, et al. HIF‐1 inhibits mitochondrial biogenesis and cellular respiration in VHL‐deficient renal cell carcinoma by repression of C‐MYC activity. Cancer Cell 2007; 11: 407–420. 145 Piret, JP, Minet, E, Cosse, JP, Ninane, N, Debacq, C, et al. Hypoxia‐inducible factor‐1‐dependent overexpression of myeloid cell factor‐1 protects hypoxic cells against tert‐butyl hydroperoxide‐induced apoptosis. J Biol Chem 2005; 280: 9336–9344. 146 Melillo, G, Musso, T, Sica, A, Taylor, LS, Cox, GW, et al. A hypoxia‐responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med 1995; 182: 1683–1693. 147 Bruick, RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci U S A 2000; 97: 9082–9087. 148 Kim, JY, Ahn, HJ, Ryu, JH, Suk, K, Park, JH. BH3‐only protein Noxa is a mediator of hypoxic cell death induced by hypoxia‐inducible factor 1α. J Exp Med 2004; 199: 113–124. 149 Choi, JW, Park, SC, Kang, GH, Liu, JO, Youn, HD. Nur77 activated by hypoxia‐inducible factor‐1α overproduces proopiomelanocortin in von Hippel‐Lindau‐mutated renal cell carcinoma. Cancer Res 2004; 64: 35–39. 150 Bhattacharya, S, Michels, CL, Leung, MK, Arany, ZP, Kung, AL, et al. Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF‐1. Genes Dev 1999; 13: 64–75. 151 Firth, JD, Ebert, BL, Pugh, CW, Ratcliffe, PJ. Oxygen‐regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc Natl Acad Sci U S A 1994; 91: 6496–6500. 152 Minchenko, A, Leshchinsky, I, Opentanova, I, Sang, N, Srinivas, V, et al. Hypoxia‐inducible factor‐1‐mediated expression of the 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase‐3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 2002; 277: 6183–6187. 153 Fukasawa, M, Tsuchiya, T, Takayama, E, Shinomiya, N, Uyeda, K, et al. Identification and characterization of the hypoxia‐responsive element of the human placental 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase gene. J Biochem (Tokyo) 2004; 136: 273–277. 154 Minchenko, O, Opentanova, I, Caro, J. Hypoxic regulation of the 6‐phosphofructo‐2‐kinase/fructose‐2,6‐bisphosphatase gene family (PFKFB‐1‐4) expression in vivo. FEBS Lett 2003; 554: 264–270. 155 Kietzmann, T, Roth, U, Jungermann, K. Induction of the plasminogen activator inhibitor‐1 gene expression by mild hypoxia via a hypoxia response element binding the hypoxia‐inducible factor‐1 in rat hepatocytes. Blood 1999; 94: 4177–4185. 156 Takahashi, Y, Takahashi, S, Shiga, Y, Yoshimi, T, Miura, T. Hypoxic induction of prolyl 4‐hydroxylase α(I) in cultured cells. J Biol Chem 2000; 275: 14139–14146. 157 Tan, M, Gu, Q, He, H, Pamarthy, D, Semenza, GL, et al. SAG/ROC2/RBX2 is a HIF‐1 target gene that promotes HIF‐1α ubiquitination and degradation. Oncogene 2008; 27: 1404–1411. 158 Miki, N, Ikuta, M, Matsui, T. Hypoxia‐induced activation of the retinoic acid receptor‐related orphan receptor α4 gene by an interaction between hypoxia‐inducible factor‐1 and Sp1. J Biol Chem 2004; 279: 15025–15031. 159 Chauvet, C, Bois‐Joyeux, B, Berra, E, Pouyssegur, J, Danan, JL. The gene encoding human retinoic acid‐receptor‐related orphan receptor α is a target for hypoxia‐inducible factor 1. Biochem J 2004; 384: 79–85. 160 Amano, H, Maruyama, K, Naka, M, Tanaka, T. Target validation in hypoxia‐induced vascular remodeling using transcriptome/ metabolome analysis. Pharmacogenomics J 2003; 3: 183–188. 161 Law, AY, Lai, KP, Ip, CK, Wong, AS, Wagner, GF, et al. Epigenetic and HIF‐1 regulation of stanniocalcin‐2 expression in human cancer cells. Exp Cell Res 2008; 314: 1823–1830. 162 Bosch‐Marcé, M, Okuyama, H, Wesley, JB, Sarkar, K, Kimura, H, et al. Effects of aging and hypoxia‐inducible factor‐1 activity on angiogenic cell mobilization and recovery of perfusion after limb ischemia. Circ Res 2007; 101: 1310–1318. 163 Han, ZB, Ren, H, Zhao, H, Chi, Y, Chen, K, et al. Hypoxia‐inducible factor (HIF)‐1α directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). Carcinogenesis 2008; 29: 1853–1861. 164 Ceradini, DJ, Kulkarni, AR, Callaghan, MJ, Tepper, OM, Bastidas, N, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF‐1 induction of SDF‐1. Nat Med 2004; 10: 858–864. 165 Zagzag, D, Krishnamachary, B, Yee, H, Okuyama, H, Chiriboga, L, et al. Stromal cell‐derived factor‐1α and CXCR4 expression in hemangioblastoma and clear cell‐renal cell carcinoma: von Hippel‐Lindau loss‐of‐function induces expression of a ligand and its receptor. Cancer Res 2005; 65: 6178–6188. 166 Nishi, H, Nakada, T, Kyo, S, Inoue, M, Shay, JW, et al. Hypoxia‐inducible factor 1 mediates upregulation of telomerase (hTERT). Mol Cell Biol 2004; 24: 6076–6083. 167 Yatabe, N, Kyo, S, Maida, Y, Nishi, H, Nakamura, M, et al. HIF‐1‐mediated activation of telomerase in cervical cancer cells. Oncogene 2004; 23: 3708–3715. 168 Rolfs, A, Kvietikova, I, Gassmann, M, Wenger, RH. Oxygen‐regulated transferrin expression is mediated by hypoxia‐inducible factor‐1. J Biol Chem 1997; 272: 20055–20062. 169 Lok, CN, Ponka, P. Identification of a hypoxia response element in the transferrin receptor gene. J Biol Chem 1999; 274: 24147–24152. 170 Tacchini, L, Fusar Poli, D, Bernelli‐Zazzera, A, Cairo, G. Transferrin receptor gene expression and transferrin‐bound iron uptake are increased during postischemic rat liver reperfusion. Hepatology 2002; 36: 103–111. 171 Caniggia, I, Mostachfi, H, Winter, J, Gassmann, M, Lye, SJ, et al. Hypoxia‐inducible factor‐1 mediates the biological effects of oxygen on human trophoblast differentiation through TGF‐β3 . J Clin Invest 2000; 105: 577–587. 172 Gort, EH, van Haaften, G, Verlaan, I, Groot, AJ, Plasterk, RH, et al. The TWIST1 oncogene is a direct target of hypoxia‐inducible factor‐2α. Oncogene 2008; 27: 1501–1510. 173 Yang, MH, Wu, MZ, Chiou, SH, Chen, PM, Chang, SY, et al. Direct regulation of TWIST by HIF‐1α promotes metastasis. Nat Cell Biol 2008; 10: 295–305. 174 Forsythe, JA, Jiang, BH, Iyer, NV, Agani, F, Leung, SW, et al. Activation of vascular endothelial growth factor gene transcription by hypoxia‐inducible factor 1. Mol Cell Biol 1996; 16: 4604–4613. 175 Gerber, H‐P, Condorelli, F, Park, J, Ferrara, N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt‐1, but not Flk‐1/KDR, is up‐regulated by hypoxia. J Biol Chem 1997; 272: 23659–23667. 176 Okuyama, H, Krishnamachary, B, Zhou, YF, Nagasawa, H, Bosch‐Marcé, M, et al. Expression of vascular endothelial growth factor receptor 1 in bone marrow‐derived mesenchymal cells is dependent on hypoxia‐inducible factor 1. J Biol Chem 2006; 281: 15554–15563. 177 Krishnamachary, B, Zagzag, D, Nagasawa, H, Rainey, K, Okuyama, H, et al. Hypoxia‐inducible factor‐1‐dependent repression of E‐cadherin in von Hippel‐Lindau tumor suppressor‐ renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res 2006; 66: 2725–2731. 178 Chen, KF, Lai, YY, Sun, HS, Tsai, SJ. Transcriptional repression of human cad gene by hypoxia inducible factor‐1α. Nucleic Acids Res 2005; 33: 5190–5198. 179 Peyssonnaux, C, Zinkernagel, AS, Schuepbach, RA, Rankin, E, Vaulont, S, et al. Regulation of iron homeostasis by the hypoxia‐inducible transcription factors (HIFs). J Clin Invest 2007; 117: 1926–1932. 180 Hartsfield, CL, Alam, J, Choi, AM. Differential signaling pathways of HO‐1 gene expression in pulmonary and systemic vascular cells. Am J Physiol 1999; 277: L1133–L1141. 181 Norris, ML, Millhorn, DE. Hypoxia‐induced protein binding to O2 ‐responsive sequences on the tyrosine hydroxylase gene. J Biol Chem 1995; 270: 23774–23770. 182 Xu, L, Xie, K, Mukaida, N, Matsushima, K, Fidler, IJ. Hypoxia‐induced elevation in interleukin‐8 expression by human ovarian carcinomal cells. Cancer Res 1999; 59: 5822–5829. 183 Taylor, CT, Fueki, N, Agah, A, Hershberg, RM, Colgan, SP. Critical role of cAMP response element binding protein expression in hypoxia‐elicited induction of epithelial tumor necrosis factor‐α. J Biol Chem 1999; 274: 19447–19454. 184 Yan, SF Zou, YS, Gao, Y, Zhai, C, Mackman, N, et al. Tissue factor transcription driven by Egr‐1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A 1998; 95: 8298–8303. 185 Yan, SF, Fujita, T, Lu, J, Okada, K, Shan Zou, Y, et al. Egr‐1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355–1361. 186 Yan, SF, Lu, J, Zou, YS, Kisiel, W, Mackman, N, et al. Protein kinase C‐ß and oxygen deprivation: a novel EGR‐1‐dependent pathway for fibrin deposition in hypoxemic vasculature. J Biol Chem 2000; 275: 11921–11928. 187 Ji, YS, Xu, Q, Schmedtje, JF Jr. Hypoxia induces high‐mobility‐group protein I(Y) and transcription of the cyclooxygenase‐2 gene in human vascular endothelium. Circ Res 1998; 83: 295–304. 188 Yan, SF, Zou, YS, Mendelsohn, M, Gao, Y, Naka, Y, et al. Nuclear factor interleukin 6 motifs mediate tissue‐specific gene transcription in hypoxia. J Biol Chem 1997; 272: 4287–4294. 189 Matsui, H, Ihara, Y, Fujio, Y, Kunisada, K, Akira, S, et al. Induction of interleukin‐6 by hypoxia is mediated by NF‐κB and NF‐IL6 in cardiac myocytes. Cardiovasc Res 1999; 42: 104–112. 190 Hehlgans, T, Seitz, C, Lewis, C, Männel, DN. Hypoxic upregulation of TNF receptor type 2 expression involves NF‐IL‐6 and is independent of HIF‐1 or HIF‐2. J Interferon Cytokine Res 2001; 21: 757–762. 191 Glasgow, JN, Qiu, J, Rassin, D, Grafe, M, Wood, T, et al. Transcriptional regulation of the BCL‐X gene by NF‐κB is an element of hypoxic responses in the rat brain. Neurochem Res 2001; 26: 647–659. 192 Chandel, NS, Trzyna, WC, McClintock, DS, Schumacker, PT. Role of oxidants in NF‐κB activation and TNF‐α gene transcription induced by hypoxia and endotoxin. J Immunol 2000; 165: 1013–1021. 193 Schmedtje, JF Jr , Ji, YS, Liu, WL, DuBois, RN, Runge, MS. Hypoxia induces cyclooxygenase‐2 via the NF‐κB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997; 272: 601–608. 194 Huang, S, Pettaway, CA, Uehara, H, Bucana, CD, Fidler, IJ. Blockade of NF‐κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 2001; 20: 4188–4197. 195 Kong, T, Scully, M, Shelley, CS, Colgan, SP. Identification of Purα as a new hypoxia response factor responsible for coordinated induction of the β2 integrin family. J Immunol 2007; 179: 1934–1941. 196 Xu, Q, Ji, YS, Schmedtje, JF Jr. Sp1 increases expression of cyclooxygenase‐2 in hypoxic vascular endothelium. J Biol Chem 2000; 275: 24583–24589. 197 Discher, DJ, Bishopric, NH, Wu, X, Peterson, CA, Webster, KA. Hypoxia regulates beta‐enolase and pyruvate kinase‐M promoters by modulating Sp1/Sp3 binding to a conserved GC element. J Biol Chem 1998; 273: 26087–26093. 198 Mole, DR, Blancher, C, Copley, RR, Pollard, PJ, Gleadle, JM, et al. Genome‐wide association of hypoxia‐inducible factor HIF‐1α and HIF‐2α DNA binding with expression profiling of hypoxia‐inducible transcripts. J Biol Chem 2009; 284: 16767–16775. 199 Xia, X, Lemieux, ME, Li, W, Carroll, JS, Brown, M, et al. Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis. Proc Natl Acad Sci U S A 2009; 106: 4260–4265. 200 Rana, TM. Illuminating the silence: Understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007; 8: 23–36. 201 Baek, D, Villén, J, Shin, C, Camargo, FD, Gygi, SP, et al. The impact of microRNAs on protein output. Nature 2008; 455: 64–71. 202 Selbach, M, Schwanhäusser, B, Thierfelder, N, Fang, Z, Khanin, R, et al. Widespread changes in protein synthesis induced by microRNAs. Nature 2008; 455: 58–63. 203 Kulshreshtha, R, Ferracin, M, Wojcik, SE, Garzon, R, Alder, H, et al. A microRNA signature of hypoxia. Mol Cell Biol 2007; 27: 1859–1867. 204 Wellmann, S, Bettkober, M, Zelmer, A, Seeger, K, Faigle, M, et al. Hypoxia upregulates the histone demethylase JMJD1A via HIF‐1. Biochem Biophys Res Commun 2008; 372: 892–897. 205 Pollard, PJ, Loenarz, C, Mole, DR, McDonough, MA, Gleadle, JM, et al. Regulation of Jumonji‐domain containing histone demethylases by hypoxia inducible factor (HIF) 1α. Biochem J 2008; 416: 387–394. 206 Ozer, A, Bruick, RK. Non‐heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nat Chem Biol 2007; 3: 144–153. 207 Gordan, JD, Bertout, JA, Hu, CJ, Diehl, JA, Simon, MC. HIF‐2α promotes hypoxic cell proliferation by enhancing c‐myc transcriptional activity. Cancer Cell 2007; 11: 335–347. 208 Yoon, D, Pastore, YD, Divoky, V, Liu, E, Mlodnicka, AE, et al. Hypoxia‐inducible factor‐1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development. J Biol Chem 2006; 281: 25703–25711. 209 Maltepe, E, Schmidt, JV, Baunoch, D, Bradfield, CA, Simon, MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 1997; 386: 403–407. 210 Peng, J, Zhang, L, Drysdale, L, Fong, GH. The transcription factor EPAS‐1/hypoxia‐inducible factor 2α plays an important role in vascular remodeling. Proc Natl Acad Sci U S A 2000; 97: 8386–8391. 211 Tian, H, Hammer, RE, Matsumoto, AM, Russell, DW, McKnight, SL. The hypoxia‐responsive transcription factor EPAS1 is essential for catecholamine homeostasis and protection against heart failure during embryonic development. Genes Dev 1998; 12: 3320–3324. 212 Compernolle, V, Brusselmans, K, Acker, T, Hoet, P, Tjwa, M, et al. Loss of HIF‐2α and inhibition of VEGF impair fetal lung maturation, whereas treatment with VEGF prevents fatal respiratory distress in premature mice. Nat Med 2002; 8: 702–710. 213 Scortegagna, M, Ding, K, Oktay, Y, et al. Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1 {−/−} mice. Nat Genet 2003; 35: 331–340. 214 Seagroves, TN, Hadsell, D, McManaman, J, Palmer, C, Liao, D, et al. HIF‐1α is a critical regulator of secretory differentiation and activation, but not vascular expansion, in the mouse mammary gland. Development 2003; 130: 1713–1724. 215 Huang, Y, Hickey, RP, Yeh, JL, Liu, D, Dadak, A, et al. Cardiac myocyte‐specific HIF‐1α deletion alters vascularization, energy availability, calcium flux, and contractility in the normoxic heart. FASEB J 2004; 18: 1138–1140. 216 Schipani, E. Hypoxia in cartilage: HIF‐1α is essential for chondrocyte growth arrest and survival. Genes Dev 2001; 15: 2865–2876. 217 Provot, S, Zinyk, D, Gunes, Y, Kathri, R, Le, Q, et al. HIF‐1α regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 2007; 177: 451–464. 218 Karhausen, J, Furuta, GT, Tomaszewski, JE, Johnson, RS, Colgan, SP, et al. Epithelial hypoxia‐inducible factor‐1 is protective in murine experimental colitis. J Clin Invest 2004; 114: 1098–1106. 219 Boutin, AT, Weidemann, A, Fu, Z, Mesropian, L, Gradin, K, et al. Epidermal sensing of oxygen is essential for systemic hypoxic response. Cell 2008; 133: 223–234. 220 Peyssonnaux, C, Boutin, AT, Zinkernagel, AS, Datta, V, Nizet, V, et al. Critical role of HIF‐1α in keratinocyte defense against bacterial infection. J Invest Dermatol 2008; 128: 1964–1968. 221 Cramer, T, Yamanishi, Y, Clausen, BE, Förster, I, Pawlinski, R, et al. HIF‐1α is essential for myeloid cell‐mediated inflammation. Cell 2003; 112: 645–657. 222 Peyssonnaux, C, Datta, V, Cramer, T, Doedens, A, Theodorakis, EA, et al. HIF‐1α expression regulates the bactericidal capacity of phagocytes. J Clin Invest 2005; 115: 1806–1815. 223 Kojima, H, Gu, H, Nomura, S, Caldwell, CC, Kobata, T, et al. Abnormal B lymphocyte development and autoimmunity in hypoxia‐inducible factor 1α‐deficient chimeric mice. Proc Natl Acad Sci U S A 2002; 99: 2170–2174. 224 Neumann, AK, Yang, J, Biju, MP, Joseph, SK, Johnson, RS, et al. Hypoxia inducible factor 1α regulates T cell receptor signal transduction. Proc Natl Acad Sci U S A 2005; 102: 17071–17076. 225 Thiel, M, Caldwell, CC, Kreth, S, Kuboki, S, Chen, P, et al. Targeted deletion of HIF‐1α gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2007; 2: e853. 226 Tomita, S, Ueno, M, Sakamoto, M, Kitahama, Y, Ueki, M, et al. Defective brain development in mice lacking the Hif‐1α gene in neural cells. Mol Cell Biol 2003; 23: 6739–6749. 227 Baranova, O, Miranda, LF, Pichiule, P, Dragatsis, I, Johnson, RS, et al. Neuron‐specific inactivation of the hypoxia inducible factor 1α increases brain injury in a mouse model of transient focal cerebral ischemia. J Neurosci 2007; 27: 6320–6332. 228 Wang, Y, Wan, C, Deng, L, Liu, X, Cao, X, et al. The hypoxia‐inducible factor α pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest 2007; 117: 1616–1626. 229 Mason, SD, Rundqvist, H, Papandreou, I, Duh, R, McNulty, WJ, et al. HIF‐1α in endurance training: suppression of oxidative metabolism. Am J Physiol 2007; 293: R2059–R2069. 230 Yu, AY, Shimoda, LA, Iyer, NV, Huso, DL, Sun, X, et al. Impaired physiological responses to chronic hypoxia in mice partially deficient for hypoxia‐inducible factor 1α. J Clin Invest 1999; 103: 691–696. 231 Shimoda, LA, Manalo, DJ, Sham, JS, Semenza, GL, Sylvester, JT. Partial HIF‐1α deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Am J Physiol 2001; 281: L202–L208. 232 Shimoda, LA, Fallon, M, Pisarcik, S, Wang, J, Semenza, GL. HIF‐1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am J Physiol 2006; 291: L941–L949. 233 Wang, J, Weigand, L, Lu, W, Sylvester, JT, Semenza, GL, et al. Hypoxia inducible factor 1 mediates hypoxia‐induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells. Circ Res 2006; 98: 1528–1537. 234 Whitman, EM, Pisarcik, S, Luke, T, Fallon, M, Wang, J, et al. Endothelin‐1 mediates hypoxia‐induced inhibition of voltage‐gated K+ channel expression in pulmonary arterial myocytes. Am J Physiol 2008; 294: 309–310. 235 Kline, DD, Peng, YJ, Manalo, DJ, Semenza, GL, Prabhakar, NR. Defective carotid body function and impaired ventilatory responses to chronic hypoxia in mice partially deficient for hypoxia‐inducible factor 1α. Proc Natl Acad Sci U S A 2002; 99: 821–826. 236 Li, J, Bosch‐Marcé, M, Nanayakkara, A, Savransky, V, Fried, SK, et al. Altered metabolic responses to intermittent hypoxia in mice with partial deficiency of hypoxia‐inducible factor 1α. Physiol Genomics 2006; 25: 450–457. 237 Peng, YJ, Yuan, G, Ramakrishnan, D, Sharma, SD, Bosch‐Marcé, M, et al. Heterozygous HIF‐1α deficiency impairs carotid body‐mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 2006; 577: 705–716. 238 Cai, Z, Zhong, H, Bosch‐Marcé, M, Fox‐Talbot, K, Wang, L, et al. Complete loss of ischemic preconditioning‐induced cardioprotection in mice with partial deficiency of HIF‐1α. Cardiovasc Res 2008; 77: 463–470. 239 Prabhakar, NR. Oxygen sensing by the carotid body chemoreceptors. J Appl Physiol 2000; 88: 2287–2295. 240 Cai, Z, Manalo, DJ, Wei, G, Rodriguez, ER, Fox‐Talbot, K, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia‐reperfusion injury. Circulation 2003; 108: 79–85. 241 Rankin, EB, Biju, MP, Liu, Q, Unger, TL, Rha, J, et al. Hypoxia‐inducible factor‐2 (HIF‐2) regulates hepatic erythropoietin in vivo. J Clin Invest 2007; 117: 1068–1077. 242 Patel, TH, Kimura, H, Weiss, CR, Semenza, GL, Hofmann, LV. Constitutively active HIF‐1α improves perfusion and arterial remodeling in an endovascular model of limb ischemia. Cardiovasc Res 2005; 68: 144–154. 243 Pajusola, K, Künnapuu, J, Vuorikoski, S, Soronen, J, André, H, et al. Stabilized HIF‐1α is superior to VEGF for angiogenesis in skeletal muscle via adeno‐associated virus gene transfer. FASEB J 2005; 19: 1365–1367. 244 Kim, JW, Tchernyshyov, I, Semenza, GL, Dang, CV. HIF‐1‐mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab 2006; 3: 177–185. 245 Papandreou, I, Cairns, RA, Fontana, L, Lim, AL, Denko, NC. HIF‐1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab 2006; 3: 187–197. 246 Tracy, K, Dibling, BC, Spike, BT, Knabb, JR, Schumacker, P, et al. BNIP3 is an RB/E2F target gene required for hypoxia‐induced autophagy. Mol Cell Biol 2007; 27: 6229–6242. 247 Zhang, H, Bosch‐Marcé, M, Shimoda, LA, Tan, YS, Baek, JH, et al. Mitochondrial autophagy is an HIF‐1‐dependent adaptive metabolic response to hypoxia. J Biol Chem 2008; 283: 10892–10903. 248 Bellot, G, Garcia‐Medina, R, Gounon, P, Chiche, J, Roux, D, et al. Hypoxia‐induced autophagy is mediated through hypoxia‐inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 2009; 29: 2570–2581. 249 Sandoval, H, Thiagarajan, P, Dasgupta, SK, Schumacher, A, Prchal, JT, et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 2008; 454: 232–235. 250 Tuder, RM, McGrath, S, Voelkel, NF, Geraci, MW. Oxygen‐dependent regulation of pulmonary circulation. Methods Enzymol 2004; 381: 87–106. 251 Bonnet, S, Michelakis, ED, Porter, CJ, Andrade‐Navarro, MA, Thébaud, B, et al. An abnormal mitochondrial‐hypoxia inducible factor‐1α‐Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension. Circulation 2006; 113: 2630–2641. 252 Yuan, G, Nanduri, J, Bhasker, CR, Semenza, GL, Prabhakar, NR. Ca2+ /calmodulin kinase‐dependent activation of hypoxia‐inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 2005; 280: 4321–4328. 253 Yuan, G, Nanduri, J, Khan, S, Semenza, GL, Prabhakar, NR. Induction of HIF‐1α expression by intermittent hypoxia: Involvement of NADPH oxidase, Ca2+ signaling, prolyl hydroxylases, and mTOR. J Cell Physiol 2008; 217: 674–685. 254 Ang, SO, Chen, H, Hirota, K, Gordeuk, VR, Jelinek, J, et al. Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia. Nat Genet 2002; 32: 614–621. 255 Percy, MJ, Zhao, Q, Flores, A, Harrison, C, Lappin, TR, et al. A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proc Natl Acad Sci U S A 2006; 103: 654–659. 256 Percy, MJ, Furlow, PW, Beer, PA, Lappin, TR, McMullin, MF, et al. A novel erythrocytosis‐associated PHD2 mutation suggests the location of a HIF binding groove. Blood 2007; 110: 2193–2196. 257 Ladroue, C, Carcenac, R, Leporrier, M, Gad, S, Le Hello, C, et al. PHD2 mutation and congenital erythrocytosis with paraganglioma. N Engl J Med 2008; 359: 2685–2692. 258 Percy, MJ, Furlow, PW, Lucas, GS, Li, X, Lappin, TR, et al. A gain‐of‐function mutation in the HIF2A gene in familial erythrocytosis. N Engl J Med 2008; 358: 162–168. 259 Perrotta, S, Della Ragione, F. The HIF2A gene in familial erythrocytosis. N Engl J Med 2008; 358: 1966. 260 Bushuev, VI, Miasnikova, GY, Sergueeva, AI, Polyakova, LA, Okhotin, D, et al. Endothelin‐1, vascular endothelial growth factor and systolic pulmonary artery pressure in patients with Chuvash polycythemia. Haematologica 2006; 91: 744–749. 261 Smith, TG, Brooks, JT, Balanos, GM, Lappin, TR, Layton, DM, et al. Mutation of von Hippel‐Lindau tumour suppressor and human cardiopulmonary physiology. PLoS Med 2006; 3: e290. 262 Hansen, J. Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 1989; 117: 290–295. 263 Clifford, SC, Astuti, D, Hooper, L, Maxwell, PH, Ratcliffe, PJ, et al. The pVHL‐associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1, and HIF‐1α in renal cell carcinoma. Oncogene 2001; 20: 5067–5074. 264 Resar, JR, Roguin, A, Voner, J, Nasir, K, Hennebry, TA, et al. Hypoxia‐inducible factor 1α polymorphism and coronary collaterals in patients with ischemic heart disease. Chest 2005; 128: 787–791. 265 Hlatky, MA, Quertermous, T, Boothroyd, DB, Priest, JR, Glassford, AJ, et al. Polymorphisms in hypoxia inducible factor 1 and the initial clinical presentation of coronary disease. Am Heart J 2007; 154: 1035–1042. 266 Zhong, H, De Marzo, AM, Laughner, E, Lim, M, Hilton, DA, et al. Overexpression of hypoxia‐inducible factor 1α in common human cancers and their metastases. Cancer Res 1999; 59: 5830–5835. 267 Talks, KL, Turley, H, Gatter, KC, Maxwell, PH, Pugh, CW, et al. The expression and distribution of the hypoxia‐inducible factors HIF‐1α and HIF‐2α in normal human tissues, cancers, and tumor‐associated macrophages. Am J Pathol 2000; 157: 411–421. 268 Semenza, GL. Targeting HIF‐1 for cancer therapy. Nat Rev Cancer 2003; 3: 721–732. 269 Kondo, K, Klco, J, Nakamura, E, Lechpammer, M, Kaelin, WG Jr . Inhibition of HIF is necessary for tumor suppression by the von Hippel‐Lindau protein. Cancer Cell 2002; 1: 237–246. 270 Semenza, GL. Evaluation of HIF‐1 inhibitors as anticancer agents. Drug Discov Today 2007; 12: 853–859. 271 Melillo, G. Targeting hypoxia cell signaling for cancer therapy. Cancer Metastasis Rev 2007; 26: 341–352. 272 Chang, EI, Loh, SA, Ceradini, DJ, Chang, EI, Lin, SE, et al. Age decreases endothelial progenitor cell recruitment through decreases in hypoxia‐inducible factor 1α stabilization during ischemia. Circulation 2007; 116: 2818–2829. 273 Liu, L, Marti, GP, Wei, X, Zhang, X, Zhang, H, et al. Age‐dependent impairment of HIF‐1α expression in diabetic mice: Correction with electroporation‐facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol 2008; 217: 319–327. 274 Botusan, IR, Sunkari, VG, Savu, O, Catrina, AI, Grünler, J, et al. Stabilization of HIF‐1α is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci U S A 2008; 105: 19426–19431. 275 Ceradini, DJ, Yao, D, Grogan, RH, Callaghan, MJ, Edelstein, D, et al. Decreasing intracellular superoxide corrects defective ischemia‐induced new vessel formation in diabetic mice. J Biol Chem 2008; 283: 10930–10938. 276 Harris, AL. Hypoxia–a key regulatory factor in tumor growth. Nat Rev Cancer 2002; 2: 38–47. 277 Rajagopalan, S, Olin, J, Deitcher, S, Pieczek, A, Laird, J, et al. Use of a constitutively active hypoxia‐inducible factor‐1α transgene as a therapeutic strategy in no‐option critical limb ischemia patients: phase I dose‐escalation experience. Circulation 2007; 115: 1234–1243. 278 Lim, JH, Park, JW, Kim, SJ, Kim, MS, Park, SK, et al. ATP6V0C competes with von Hippel‐Lindau protein in hypoxia‐inducible factor 1α (HIF‐1α) binding and mediates HIF‐1α expression by bafilomycin A1. Mol Pharmacol 2007; 71: 942–948.